| Serial Number | 88020634 |
| Word Mark | EARLI |
| Filing Date | Friday, June 29, 2018 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, March 14, 2023 |
| Registration Number | 7000700 |
| Registration Date | Tuesday, March 14, 2023 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, January 14, 2020 |
| Goods and Services | Pharmaceutical and veterinary preparations and products for the prevention, detection, localization, and treatment of cancer, respiratory diseases, and liver diseases; Drug delivery agents in the form of compounds that facilitate the delivery of other pharmaceutical products into human and animal bodies; clinical medical diagnostic or therapeutic reagents and clinical diagnostic kits comprised of clinical medical diagnostic or therapeutic reagents; medical diagnostic or therapeutic reagents and medical diagnostic or therapeutic kits comprised of medical diagnostic or therapeutic reagents; reagents for medical use and medical diagnostics or therapeutics and screening kits comprised of reagents for medical diagnostics and screening use or therapeutics; reagents for use in testing for medical and medical diagnostic purposes; diagnostic and therapeutic preparations for medical purposes, namely, to detect and treat cancer, respiratory diseases, and liver diseases; diagnostic or therapeutic assays, vectors, reagents, enzymes, and nucleotides for medical or clinical purposes; diagnostic or screening assays, reagents, enzymes, and nucleotides for medical diagnostic purposes and treatment purposes, namely, to detect and treat cancer, respiratory diseases, and liver diseases; reagents for medical diagnostic purposes and treatment use; therapeutic agents for medical diagnostic purposes and treatment, namely, viral vectors and non-viral transfection agents based on linear or branched polyethylenimines, nanoparticles, lipophilic particles, peptides, micelles, dendrimers, hydrogels, synthetic or naturally derived exosomes, polymeric composition, or virus-like particles, which facilitate the delivery of pharmaceuticals or nucleic acids into human and animal bodies to detect and treat cancer, respiratory diseases, and liver diseases |
| Goods and Services | Assays, recombinant nucleic acid vectors, transfection agents, reagents, enzymes, and nucleotides for clinical or medical laboratory, scientific, or research purposes; diagnostic or screening assays or agents, reagents, enzymes, and nucleotides for clinical or medical laboratory, scientific, and research, purposes; reagents for medical and genetic research; chemical reagents and diagnostic preparations for clinical or medical laboratory use |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, July 5, 2018 |
| Primary Code | 001 |
| First Use Anywhere Date | Wednesday, January 18, 2023 |
| First Use In Commerce Date | Wednesday, January 18, 2023 |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, July 5, 2018 |
| Primary Code | 005 |
| First Use Anywhere Date | Wednesday, January 18, 2023 |
| First Use In Commerce Date | Wednesday, January 18, 2023 |
| Party Name | Earli Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Mountain View, CA 94022 |
| Party Name | Earli Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Mountain View, CA 94022 |
| Party Name | Earli Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Mountain View, CA 94022 |
| Event Date | Event Description |
| Tuesday, March 14, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, March 14, 2023 | REGISTERED-PRINCIPAL REGISTER |
| Friday, February 10, 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Thursday, February 9, 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Thursday, February 2, 2023 | STATEMENT OF USE PROCESSING COMPLETE |
| Tuesday, January 31, 2023 | USE AMENDMENT FILED |
| Tuesday, January 31, 2023 | TEAS STATEMENT OF USE RECEIVED |
| Wednesday, January 18, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, January 17, 2023 | SOU EXTENSION 5 GRANTED |
| Thursday, December 15, 2022 | SOU EXTENSION 5 FILED |
| Wednesday, January 4, 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Thursday, December 15, 2022 | SOU TEAS EXTENSION RECEIVED |
| Thursday, June 16, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, June 14, 2022 | SOU EXTENSION 4 GRANTED |
| Tuesday, June 14, 2022 | SOU EXTENSION 4 FILED |
| Tuesday, June 14, 2022 | SOU TEAS EXTENSION RECEIVED |
| Saturday, December 18, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, December 16, 2021 | SOU EXTENSION 3 GRANTED |
| Thursday, December 16, 2021 | SOU EXTENSION 3 FILED |
| Thursday, December 16, 2021 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, May 18, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, May 14, 2021 | SOU EXTENSION 2 GRANTED |
| Friday, May 14, 2021 | SOU EXTENSION 2 FILED |
| Friday, May 14, 2021 | SOU TEAS EXTENSION RECEIVED |
| Thursday, December 24, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, December 22, 2020 | SOU EXTENSION 1 GRANTED |
| Tuesday, December 22, 2020 | SOU EXTENSION 1 FILED |
| Tuesday, December 22, 2020 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, July 14, 2020 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, June 4, 2020 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
| Thursday, February 13, 2020 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| Tuesday, January 14, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, January 14, 2020 | PUBLISHED FOR OPPOSITION |
| Wednesday, December 25, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, December 11, 2019 | ASSIGNED TO LIE |
| Monday, December 9, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 20, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, November 19, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, November 19, 2019 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Monday, May 20, 2019 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Monday, May 20, 2019 | FINAL REFUSAL E-MAILED |
| Monday, May 20, 2019 | FINAL REFUSAL WRITTEN |
| Tuesday, April 30, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, April 29, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, April 29, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, October 29, 2018 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, October 29, 2018 | NON-FINAL ACTION E-MAILED |
| Monday, October 29, 2018 | NON-FINAL ACTION WRITTEN |
| Monday, October 22, 2018 | ASSIGNED TO EXAMINER |
| Thursday, July 5, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, July 3, 2018 | NEW APPLICATION ENTERED |